Share on StockTwits

Medidata Solutions (NASDAQ:MDSO) EVP Bryan Charles Spielman sold 2,261 shares of the company’s stock in a transaction dated Monday, August 4th. The stock was sold at an average price of $45.00, for a total value of $101,745.00. Following the transaction, the executive vice president now directly owns 62,453 shares of the company’s stock, valued at approximately $2,810,385. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Shares of Medidata Solutions (NASDAQ:MDSO) traded down 0.78% during mid-day trading on Wednesday, hitting $44.29. 262,218 shares of the company’s stock traded hands. Medidata Solutions has a 52-week low of $32.10 and a 52-week high of $68.21. The stock’s 50-day moving average is $41.84 and its 200-day moving average is $48.55. The company has a market cap of $2.323 billion and a price-to-earnings ratio of 365.90.

Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Tuesday, July 29th. The company reported $0.17 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.18 by $0.01. The company had revenue of $83.20 million for the quarter, compared to the consensus estimate of $81.90 million. During the same quarter last year, the company posted $0.36 earnings per share. Medidata Solutions’s revenue was up 22.2% compared to the same quarter last year. On average, analysts predict that Medidata Solutions will post $0.76 earnings per share for the current fiscal year.

A number of research firms have recently commented on MDSO. Analysts at Stifel Nicolaus raised their price target on shares of Medidata Solutions from $47.00 to $55.00 in a research note on Thursday, July 31st. Separately, analysts at Topeka Capital Markets reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday, July 30th. They now have a $50.00 price target on the stock, up previously from $49.00. Finally, analysts at Jefferies Group raised their price target on shares of Medidata Solutions from $50.00 to $53.00 in a research note on Wednesday, July 30th. They now have a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $58.37.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Receive News & Ratings for Medidata Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.